Epsilon M&A Deal Report - SynerLAB France
Transaction Multiples for the Valuation of Private Companies
Private Group Led by AXA Private Equity Fund / SynerLAB France
No EMAT :
17725
Announced Date :
25/04/2007
Type :
SBO (Secondary Buy Out) ,Exit
Deal Value :
Yes
Acquirer :
Private Group Led by AXA Private Equity Fund
Target :
SynerLAB France
Country :
France
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Groupe SynerLab is one of the leading French pharma Contract Manufacturing Organisations (CMO) of generic and ethical pharmaceutical products (i.e. patent protected and prescription sales) supplying...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
| Date | Acquirer | Target | Country | Multiples | See details |
| 27/06/2007 | Mentor | Perouse Plastie | France | * | 17466 |
| 26/03/2007 | BUPA Iberia SL (Grupo Sanitas) | Euroresidencias Gestion | Spain | * | 17456 |
Source: Epsilon Research / EMAT
